Huntsman Corporation

HUN • Chemicals

$9.62

▲ +0.22 (+2.34%)

Current price

EarningsLatest report: Jun 30, 2026

HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.

Market Cap

$1.66B

Growth

3.2%

Cash Flow

4/5

Trend

Mostly stable

Evidence

Positive free cash flow · 0.67Consistent free cash flow · 4/5Negative growth trendWeak profitability

Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$9.62

Change2.34%

Shares Out173.00M

Market Cap$1.66B

Enterprise Value$3.41B

52W Range7.30 - 16.09

Beta0.71

P/E-13.64

P/S0.28

P/B0.24

P/FCF-184.92

EV/Sales0.58

Price$9.62

Change2.34%

Shares Out173.00M

Market Cap$1.66B

Enterprise Value$3.41B

52W Range7.30 - 16.09

Beta0.71

P/E-13.64

P/S0.28

P/B0.24

P/FCF-184.92

EV/Sales0.58

EV/EBITDA15.77

EV/FCF-378.36

Earnings Yield-7.33%

FCF Yield-0.54%

Dividend Yield4.51%

Gross Margin13.21%

Oper. Margin-0.69%

Profit Margin-4.84%

Debt/Eq0.99

Current Ratio1.30

Quick Ratio0.78

Revenue 5Y3.16%

Target$12.00

Target Upside24.74%

Target Median$11.50

Target Range10.00 - 16.00

Volume3.40M

Avg Volume5.84M

EPS Surprise0.03

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

27/100

Financial Strength

Debt, cash, stability

50/100

Growth Potential

Revenue and expansion

20/100

Price Attractiveness

Cheap or expensive today

84/100

Why this score▼

Positive free cash flow · 0.67Consistent free cash flow · 4/5Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

HUN

Analyst sentiment

Based on 33 analyst votes · 2026-09-05

68/100

Neutral

Bullish

Hold

Bearish

Price Target

2026-07-31

Low

$12.00

Mean

$13.75

Median

$14.00

High

$15.00

Company Overview

IPO: 2/14/2005

Industry: Chemicals

P/B i: 0.24

Debt / Equity i: 0.99

Operating Margin: -0.69%

Net Margin: -4.84%

ROE i: -

ROIC: -

Financial Health

Score10 / 20

Debt / Equity: 0.99

Current Ratio: 1.30

Quick Ratio: 0.78

Status: Moderate

Insider Transactions

Recent executive and insider activity

Huntsman Peter R

Transaction: 02/13/2026

SELL

Change

-19,184

Price

$13.21

Filing

02/17/2026

Type

SELL

Benko Brittany

Transaction: 02/13/2026

SELL

Change

-1,281

Price

$13.21

Filing

02/17/2026

Type

SELL

Lister Philip M.

Transaction: 02/13/2026

SELL

Change

-3,706

Price

$13.21

Filing

02/17/2026

Type

SELL

Insider	Type	Change	Price	Transaction	Filing
Huntsman Peter R	SELL	-19,184	$13.21	02/13/2026	02/17/2026
Benko Brittany	SELL	-1,281	$13.21	02/13/2026	02/17/2026
Lister Philip M.	SELL	-3,706	$13.21	02/13/2026	02/17/2026
Buberl Jan	SELL	-1,514	$13.21	02/13/2026	02/17/2026
Hansen Steen Weien	SELL	-1,513	Not reported	02/13/2026	02/17/2026
Hansen Steen Weien	SELL	-449	$13.21	02/13/2026	02/17/2026
Jorgensen Steven C.	SELL	-583	$13.21	02/13/2026	02/17/2026
Wright Scott J	SELL	-2,096	$13.21	02/13/2026	02/17/2026
Rogers Robert Wade	SELL	-2,329	$13.21	02/13/2026	02/17/2026
Huntsman Peter R	BUY	+372,268	Not reported	02/12/2026	02/17/2026
Munoz Barcelo Jose Antonio	BUY	+12,434	Not reported	02/12/2026	02/17/2026
McGovern Jeanne	BUY	+12,434	Not reported	02/12/2026	02/17/2026
Beckerle Mary C	BUY	+12,434	Not reported	02/12/2026	02/17/2026
Benko Brittany	BUY	+26,375	Not reported	02/12/2026	02/17/2026
Lister Philip M.	BUY	+69,706	Not reported	02/12/2026	02/17/2026
Smedley Amy Kay	BUY	+56,518	Not reported	02/12/2026	02/17/2026
DULA SONIA	BUY	+12,434	Not reported	02/12/2026	02/17/2026
ESPELAND CURTIS E	BUY	+12,434	Not reported	02/12/2026	02/17/2026
Ferrari Daniele	BUY	+12,434	Not reported	02/12/2026	02/17/2026
Egan Cynthia	BUY	+12,434	Not reported	02/12/2026	02/17/2026

About the Company

Huntsman Corporation

Huntsman Corporation operates as a global producer and marketer of specialized organic chemical compounds. Its operations are structured across four distinct business divisions: Polyurethanes, Performance Products, Advanced Materials, and Textile Effects. The Polyurethanes division supplies a range of polyurethane-based chemicals, such as methyl diphenyl diisocyanate (MDI), polyols, thermoplastic polyurethane (TPU), propylene oxide, and methyl tertiary-butyl ether. Within Performance Products, the company produces a variety of amines and maleic anhydrides, alongside other key chemicals like ethylene oxide, propylene oxide, glycols, ethylene dichloride, caustic soda, ammonia, hydrogen, methylamines, and acrylonitrile. The Advanced Materials segment focuses on advanced polymer solutions. This includes formulations based on epoxy, acrylic, polyurethane, and acrylonitrile-butadiene, as well as high-performance thermoset resins, curing and toughening agents, carbon nanotube additives, and fundamental liquid and solid resins. Finally, the Textile Effects division delivers specialized chemicals and dyes for the textile industry. Huntsman's diverse product portfolio finds extensive application across numerous industries. These span from adhesives, aerospace components, and automotive manufacturing to various construction materials, consumer goods (both durable and non-durable), electronics, insulation, and medical devices. Additionally, their chemicals are vital in packaging, coatings, power generation, refining, synthetic fibers, and the textile and dye sectors. Established in 1970, Huntsman Corporation maintains its corporate headquarters in The Woodlands, Texas.

Source - link

Peers

ASPI BAK CC CRML IPX KALU LAC SVM TGB VZLA

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

BlackRock Inc. Invests $193.75 Million in Huntsman Corporation $HUN

BlackRock Inc. bought a new position in shares of Huntsman Corporation (NYSE: HUN) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 18,243,856 shares of the basic materials company's stock, valued at approximately $193,750,000. BlackRock Inc. owned 10.40% of Huntsman as of its

Defense World

Huntsman Stockholders Approve Olin Merger Agreement at Special Meeting

Huntsman NYSE: HUN stockholders approved the company's proposed merger agreement with Olin Corporation during a virtual special meeting held in 2026, clearing a key shareholder-vote requirement for the planned business combination.

MarketBeat

OLN-HUN's All-Stock Merger of Equals Approved by Shareholders

Olin and Huntsman's shareholders overwhelmingly back their all-stock merger, advancing a $12.5 billion chemicals combination targeting more than $400 million in benefits.

Zacks Investment Research

OLIN and HUNTSMAN Shareholders Approve Transformative Merger of Equals

OLIN and HUNTSMAN Shareholders Approve Transformative Merger of Equals PR Newswire CLAYTON, Missouri and THE WOODL

GuruFocus

OLIN and HUNTSMAN Shareholders Approve Transformative Merger of Equals

CLAYTON, Missouri and THE WOODLANDS, Texas, Aug. 25, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN) and Huntsman Corporation (NYSE: HUN) today announced that their respective shareholders have approved the proposals necessary to complete the companies' previously announced all-stock merger of equals. "We greatly appreciate the strong support of Olin and Huntsman shareholders as we reach this important milestone," said Ken Lane, President and Chief Executive Officer of Olin.

PRNewsWire

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-04-30	-0.23	-0.2	0.03
2026-02-17	-0.29	-0.37	-0.08
2025-11-06	-0.13	-0.03	0.1
2025-07-31	-0.15	-0.2	-0.05
2025-05-01	-0.11	-0.11	0
2025-02-17	-0.07	-0.25	-0.18
2024-11-04	0.09	0.1	0.01
2024-08-05	0.14	0.14	0
2024-05-02	-0.08	-0.06	0.02
2024-02-21	-0.14	-0.21	-0.07
2023-10-31	0.19	0.15	-0.04
2023-07-31	0.29	0.22	-0.07